Pricing Log in Create free account
Saturday 17 October 2026 Export LLY’s income statement to Excel — free account

Eli Lilly and Company

LLY Healthcare Drug Manufacturers General

Eli Lilly and Company’s revenue for fiscal 2025 (year ended December 2025) was $65.2 billion, up 44.7% from fiscal 2024. In the quarter to June 2026, revenue grew 47.7%, EPS grew 26.2%, free cash flow grew 458.1% and total debt rose 37.6%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for five.

1,257.03 5.42 +0.43%
Market cap
$1.18T
P/E
42.2×
Fwd P/E
33.1×
Dividend yield
0.53%
F-score
7/9
Altman Z
8.61
Beneish M
−1.91
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Eli Lilly and Company (LLY) Operating margin

Alert me on Operating margin

Eli Lilly and Company's operating margin over the twelve months to 30 June 2026 was 42.2%, up 1.9 percentage points from fiscal 2025 (40.4%). Over the past ten years it has ranged from 10.0% (fiscal 2017) to 40.4% (fiscal 2025) — the current reading is the highest in ten years. That is above the Drug Manufacturers General industry median of 18.8% and above the Healthcare sector median of 0.00%.

Operating margin, annual

Embed this chart

Annual newest first

Period Operating margin Change (points)
FY2025 40.4% 11.71
FY2024 28.6% 9.72
FY2023 18.9% (6.05)
FY2022 25.0% 2.52
FY2021 22.5% (2.24)
FY2020 24.7% 2.40
FY2019 22.3% 5.85
FY2018 16.4% 6.41
FY2017 10.0% (5.34)
FY2016 15.4% 1.90

Quarterly newest first

Period Operating margin Change (points)
Jun 2026 39.1% (5.95)
Mar 2026 45.0% 1.62
Dec 2025 43.4% 1.56
Sep 2025 41.9% (2.29)
42 more quarters

Against its own ten years

Low 10.0% High 40.4%
Ten-year median 22.3%
Current reading's percentile 98

Operating margin against peers

Company Operating margin
LLY Eli Lilly and Company 42.2%
NVS Novartis AG compare 30.2%
AMGN Amgen Inc. compare 30.0%
ABBV AbbVie Inc. compare 26.2%
AZN AstraZeneca PLC compare 22.8%
PFE Pfizer Inc. compare 21.7%
JNJ Johnson & Johnson compare 19.3%
MRK Merck & Co., Inc. compare 10.5%
GILD Gilead Sciences, Inc. compare −8.20%
Drug Manufacturers General industry median 18.8%
Healthcare sector median 0.00%
Market median 0.00%

What Operating margin is

EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.

EBIT ÷ Revenue

The full definition of Operating margin →

More on LLY